Hans-Joachim Knölker
Corporate Officer/Principal at Hanover College
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew P. Forrester | M | 67 |
Hanover College
| - |
| Ulrich Wilhelm Jaroni | M | 73 |
Dresden University of Technology
| 13 years |
| James Anderson | M | 52 |
Hanover College
| - |
| Mark Arnold Levett | M | - |
Hanover College
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gary Jennings | M | 60 |
JADO Technologies GmbH
 JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | 13 years |
| Kai Simons | M | 86 |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | 13 years |
| Foruhar Madjlessi | M | 56 |
University of Karlsruhe
| 10 years |
| Tobias Braxmeier | M | 56 |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany.
University of Karlsruhe
| 3 years |
| John Shoemaker | M | 81 |
Hanover College
| 10 years |
| Gavin Wayne Stephens | M | - |
Hanover College
| 4 years |
| Ralph Müller | M | 53 |
University of Karlsruhe
| 4 years |
| Guan Ming Zhang | M | 59 |
Dresden University of Technology
| 2 years |
| Anja Kleber | F | - |
University of Karlsruhe
| 5 years |
| Jens Luehring | M | 50 |
Hanover College
| 1 years |
| Ryan Timothy Shepherd | M | - |
Hanover College
| 4 years |
| Katja Kipping | F | 46 |
Dresden University of Technology
| 1 years |
| Ron Patberg | M | - |
Hanover College
| 4 years |
| Harald Popp | M | 53 |
University of Karlsruhe
| 4 years |
| Reiner Piske | M | 54 |
University of Karlsruhe
| 7 years |
| Philipp Lattermann | M | - |
Dresden University of Technology
| 3 years |
| Will B. Lundstrom | M | - |
Hanover College
| 4 years |
| Dirk Marzluf | M | 54 |
University of Karlsruhe
| 6 years |
| Christopher Webb | M | - |
Hanover College
| 4 years |
| Daniel Schmitt | M | - |
University of Karlsruhe
| 5 years |
| Theodora Monohartzi | F | - |
Hanover College
| 2 years |
| Jens Eisenschmidt | M | - |
Dresden University of Technology
| 3 years |
| Ray Kramer | M | - |
Hanover College
| 4 years |
| Nancy Böhning | F | 45 |
Dresden University of Technology
| 7 years |
| Tobias Ohler | M | 53 |
University of Karlsruhe
| 3 years |
| Stefanie Frensch | F | 54 |
University of Karlsruhe
| 1 years |
| Wei Qi Ye | M | 60 |
Dresden University of Technology
| 2 years |
| Torsten Macko | M | 55 |
University of Karlsruhe
| 4 years |
| Wolfgang Friebauer | M | 64 |
University of Karlsruhe
| 1 years |
| Scott Hill | M | - |
Hanover College
| 4 years |
| Aimee Billow Forsythe | F | - |
Hanover College
| 4 years |
| Jan Blochwitz-Nimoth | M | 54 |
Dresden University of Technology
| 3 years |
| Reimar Schlingensiepen | M | - |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | 5 years |
| Marino Zerial | M | - |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | 13 years |
| Teymuras Kurzchalia | M | - |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | 13 years |
| Charl van Zyl | M | 57 |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | 2 years |
| Eike Boehm | M | 62 |
University of Karlsruhe
| 3 years |
| Martin Brudy | M | - |
University of Karlsruhe
| 3 years |
| Fei Huang | F | 59 |
Dresden University of Technology
| 2 years |
| Christopher Welker | M | - |
Hanover College
| 4 years |
| Ines Kaestner | F | 47 |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | - |
| Dieter Köster | M | 76 |
Dresden University of Technology
| 1 years |
| Stephan Kirschbaum | M | 57 |
University of Karlsruhe
| 3 years |
| En Min Chen | M | 40 |
Dresden University of Technology
| 2 years |
| Wes Barnes | M | - |
Hanover College
| 4 years |
| Marc Schröder | M | 54 |
University of Karlsruhe
| 5 years |
| Michael Albrecht | M | 74 |
Dresden University of Technology
| 3 years |
| Hordur Thorhallsson | M | - |
University of Karlsruhe
| 1 years |
| Wei Li | M | 55 |
Dresden University of Technology
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 37 | 69.81% |
| United States | 16 | 30.19% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hans-Joachim Knölker
- Personal Network
